Corona vaccines and logistics

Michael Foeth is Head of Swiss Industrial Research at Vontobel. He joined Vontobel in 2006 as a financial analyst specializing on technology, business services and logistics, and was involved in numerous IPOs in those sectors. Previously, he spent six years with Lombard Odier & Cie, responsible for the coverage of technology and logistics companies. Michael Foeth lectured science and technology at the University of Geneva between 1999 and 2005. He holds PhD in Physics from the ETH Lausanne (EPFL), a masters degree in Physics from the University of Geneva, and is a CFA charterholder.

Stefan Schneider joined Vontobel in February 2015 as Head of Life Sciences. Prior to that, he worked for ten years for the CIO WM Research Team at UBS, where he headed the European Equity Research and Equity Healthcare Research teams. Before his career in the financial sector, Mr. Schneider held senior positions at Roche.

Stefan Schneider holds a Ph.D. from the Institute of Medical Virology at University Zurich and is a CFA charterholder.

Peter Romanzina joined Vontobel as Head of Brokerage in September 2010. He began his career at various banks in portfolio and asset management in Geneva, London, and Zurich before joining Schweizerische Kreditanstalt (SKA) in 1995. At SKA and later for Credit Suisse/First Boston (CSFB), he began as a research salesman for Swiss equities in Zurich and London. From 1998 to 2000, he headed Swiss Equity Research for CSFB and was also responsible for the Swiss equity strategy. From 2001 to 2010, he headed the brokerage business in Switzerland for Kepler (formerly Julius Baer) and was a member of the European Management Board.

Peter Romanzina is chartered financial analyst (CFA), financial risk manager (FRM), certified financial analyst and portfolio manager (CIIA).